Ultra-Processed Food, Crohn's Risk and Low DHA: New Study

On September 16, 2026, researchers published a multicohort metabolomic and genetic study in Clinical Gastroenterology and Hepatology reporting that a 73-metabolite blood signature linked to ultra-processed food intake was associated with a higher risk of developing Crohn's disease. While the findings provide fresh biological clues about how highly processed diets might influence gut inflammation, the study analyzed blood biomarkers rather than specific packaged products, and it did not test any diet change or supplement in people.

Key takeaways

• Increased Crohn's risk: A stronger ultra-processed blood metabolic signature was linked to an increased risk of Crohn's disease, showing a hazard ratio of 2.65 per standard deviation (95% CI 1.57-4.48).
• DHA in the middle: Lower circulating DHA, an omega-3 fatty acid, mediated 17.1% of the link between the signature and Crohn's disease.
• Genetic validation: Mendelian randomization identified an odds ratio of 0.70 (95% CI 0.60-0.81) for DHA on Crohn's risk, pointing to the FADS1 gene locus (rs174546).
• No clinical supplement advice: The research team did not test fish oil or DHA pills in patients, and the study does not establish supplement recommendations for consumers.

What happened

On September 16, 2026, a research team led by S. Wang, L. Dan, X. Ruan, J. Wellens, and colleagues published a study titled "Integrated metabolomic and genetic profiling implicate loss of docosahexaenoic acid in the link between ultra-processed foods and Crohn's disease" in the peer-reviewed journal Clinical Gastroenterology and Hepatology (DOI 10.1016/j.cgh.2026.09.004; PubMed record). The journal is an official publication of the American Gastroenterological Association.

To explore how dietary patterns register biologically in the bloodstream, the authors constructed a high-throughput metabolic profile using circulating metabolite data from 10,229 participants in the UK Biobank discovery cohort. By applying elastic net regression, they distilled this complex data into a validated 73-metabolite signature reflecting ultra-processed food intake.

The team then tested and validated the 73-metabolite signature internally across 91,306 participants and externally in 7,893 individuals from the Whitehall-II Study, yielding Spearman correlation coefficients between 0.20 and 0.25 across groups. Key drivers from this profile were further confirmed in 752 participants across two Western cohorts and one Eastern cohort via the ONE-IBD study group.

Crossref metadata shows that the research received grant backing from the National Natural Science Foundation of China and the China Postdoctoral Science Foundation.

What changed

Historically, nutritional epidemiology linking industrial food intake to inflammatory bowel disease has relied heavily on participant memory and food frequency questionnaires.

When evaluating health outcomes, the researchers found that participants exhibiting a more pronounced 73-metabolite signature faced an elevated risk of developing Crohn's disease, with a hazard ratio of 2.65 per standard deviation (95% CI 1.57-4.48). The investigators did not report results for ulcerative colitis in the abstract, keeping the focus specifically on Crohn's disease.

Docosahexaenoic acid (DHA), an omega-3 fatty acid, was among the most consistently prioritized metabolites. Lower circulating DHA mediated 17.1% of the association between the ultra-processed food signature and Crohn's disease, and validation in the ONE-IBD cohorts supported DHA as a link between ultra-processed food and Crohn's incidence. The authors concluded that lower DHA "may represent one metabolic pathway" linking ultra-processed food intake to Crohn's risk.

To probe whether this DHA depletion reflects cause or merely correlation, the investigators conducted Mendelian randomization, which uses natural genetic variation as an instrumental variable. Their analysis demonstrated a protective effect of DHA against Crohn's disease, showing an odds ratio of 0.70 (95% CI 0.60-0.81). Genetic colocalization analysis further implicated rs174546 within the FADS1 gene locus as a key genetic locus.

Who is affected

Crohn's disease is a chronic inflammatory disorder of the digestive tract that can affect individuals of any age, causing abdominal pain, severe diarrhea, weight loss, and fatigue. Genetics is a known risk factor, and researchers are increasingly studying the role of diet.

The study examined blood samples across diverse adult cohorts, notably the UK Biobank and Whitehall-II cohorts, with additional cross-validation across three cohorts in the ONE-IBD framework. However, the study abstract did not disclose specific demographic breakdowns such as mean age, participant sex splits, baseline nutritional deficiencies, or the absolute count of incident Crohn's cases documented across the follow-up window.

Because the research relies on population-scale observational cohorts and genetic modeling, the results describe averages across large groups, not what will happen to any one person.

Importantly, the paper did not evaluate specific consumer brands, nor did it single out particular emulsifiers or industrial texturizers on supermarket shelves.

What it means for shoppers

For everyday consumers browsing grocery aisles, the practical takeaway requires nuance. This research evaluated a standard-deviation increase in a complex 73-metabolite blood profile, not an exact serving threshold, gram weight, or single offending ingredient.

Shoppers should not view this study as an indictment of any single item or additive. For example, shoppers evaluating common thickeners on packaged items often ask questions like Is Carrageenan Safe? Uses, Safety, and Regulatory Status, or examine everyday binders by checking Is Soy Lecithin Safe? Uses, Allergy Facts, and Label Names. The study does not identify specific food additives as single culprits behind the 73-metabolite profile.

Rather than pointing at individual texturizers, the findings suggest that ultra-processed eating patterns may coincide with lower blood levels of DHA, an omega-3 fatty acid.

Shoppers should also avoid jumping to dietary extremes. The study authors explicitly framed their findings as potential targets for precision nutrition in future clinical trials. They did not test DHA supplements, fish-oil capsules, or specific whole-food interventions in humans, and they did not issue supplement recommendations for preventing inflammatory disease.

Consumers interested in checking the balance of their packaged groceries can use digital tools to clarify formulations:

• Inspect the ingredient statement for extensive lists of refined starches, isolated proteins, and multiple added colors, flavors and emulsifiers.
• Review the Nutrition Facts panel directly for baseline fat profiles, sodium, and added sugars.
• Keep in mind that blood metabolite levels reflect the full dietary matrix rather than a single packaged snack.

The background

For years, observational studies have pointed toward an association between diets high in industrial formulations and chronic health conditions. Yet interpreting this evidence has remained difficult because public health bodies and regulatory authorities lack consistent standards for categorizing these items.

The U.S. Food and Drug Administration (FDA) ultra-processed foods page, last updated September 18, 2025, says there is no federal definition of ultra-processed foods yet. To address that gap, the FDA and the U.S. Department of Agriculture (USDA) issued a joint Request for Information on July 24, 2025, seeking scientific input to establish a uniform definition for regulatory and labeling purposes.

Without a standardized federal framework, researchers have historically depended on broad classification tools like NOVA, which group foods according to the extent and purpose of industrial processing. However, the abstract for the September 16, 2026, study did not disclose which specific classification method or dietary assessment tool, such as multi-day 24-hour dietary recalls or food frequency questionnaires, was used to measure participant food intake initially.

This lack of exposure granularity is why researchers turned to high-resolution blood metabolomics. By identifying a distinct 73-metabolite signature, the authors sought an objective biological readout of dietary patterns that depends less on self-reported questionnaires, paving the way for more rigorous mechanistic research.

What to watch next

In the scientific community, the next major hurdle will be designing controlled intervention trials.

Several research limitations remain unaddressed by the published abstract:

• The total follow-up duration and the exact number of diagnosed Crohn's cases were not disclosed.
• The abstract omitted participant age ranges and specific baseline health exclusions.
• It remains unverified whether targeted dietary changes can reliably reverse the 73-metabolite profile in real-world human populations.

On the regulatory side, the FDA page cited here predates any later US definition steps, so check FDA for updates on a federal definition of ultra-processed foods.

To understand what is inside the packaged items on your shelves, you can use the Aurascan app to inspect ingredients individually with transparent, cited evidence.